selected publications
-
conference proceeding
- Methyl urea-substituted pyridines as a new class of glucokinase activators. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 2014
-
journal article
-
C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.
ACS Medicinal Chemistry Letters.
1284-1289.
2014
-
Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA Inhibitors.
ACS Medicinal Chemistry Letters.
705-709.
2012
- Preclinical characterization of ARRY-575: a potent, selective, and orally bio-available small molecule inhibitor of Chk1. Annals of Oncology. 23-23. 2011
-
Single-Agent Inhibition of Chk1 Is Antiproliferative in Human Cancer Cell Lines In Vitro and Inhibits Tumor Xenograft Growth In Vivo.
Oncology Research.
349-363.
2011
-
Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases.
Journal of Medicinal Chemistry.
4672-4684.
2008
-
Total synthesis of (+)-phomactin A using a B-alkyl Suzuki macrocyclization.
Journal of the American Chemical Society.
1712-1713.
2003
-
Convergent enantioselective synthesis of the tricyclic core of phomactin A.
Organic Letters.
2413-2416.
2002
- Progress toward the synthesis of phomactin.. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. U33-U33. 2000
- Progress toward the total synthesis of phomactin A.. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. U224-U224. 2000
-
C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.
ACS Medicinal Chemistry Letters.
1284-1289.
2014